Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 8, 2022
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
Jessica Tassan Maintained (TDOC) at Buy with Decreased Target to $104 on, Mar 8th, 2022
Jessica Tassan of Piper Sandler, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $108 to $104 on, Mar 8th, 2022.
Jessica has made no other calls on TDOC in the last 4 months.
There are 19 other peers that have a rating on TDOC. Out of the 19 peers that are also analyzing TDOC, 7 agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $78 on, Thursday, February 24th, 2022
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $74 on, Wednesday, February 23rd, 2022
- Matt Hewitt of "Craig-Hallum" Maintained at Hold with Decreased Target to $67 on, Wednesday, February 23rd, 2022
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $77 on, Wednesday, February 23rd, 2022
- Glen Santangelo of "Jefferies" Maintained at Hold with Decreased Target to $82 on, Monday, February 7th, 2022
- David Larsen of "BTIG" Downgraded from Strong Buy to Hold on, Monday, November 22nd, 2021
- Scott Schoenhaus of "Stephens & Co." Maintained at Hold with Decreased Target to $135 on, Friday, November 19th, 2021
These are the ratings of the 12 analyists that currently disagree with Jessica
- John Eade of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $95 on, Thursday, March 3rd, 2022
- Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $114 on, Friday, February 25th, 2022
- Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $100 on, Wednesday, February 23rd, 2022
- Lisa Gill of "JP Morgan" Maintained at Buy with Decreased Target to $125 on, Wednesday, February 23rd, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $130 on, Wednesday, February 23rd, 2022
- Ryan MacDonald of "Needham" Maintained at Strong Buy with Decreased Target to $100 on, Wednesday, February 23rd, 2022
- Stephanie Davis Demko of "SVB Leerink" Maintained at Buy with Decreased Target to $161 on, Wednesday, February 23rd, 2022
- Cindy Motz of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Friday, February 11th, 2022
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $160 on, Tuesday, November 23rd, 2021
- Daniel Grosslight of "Citigroup" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 19th, 2021
- Stephanie Davis of "SVB Leerink" Maintained at Buy with Decreased Target to $193 on, Friday, November 19th, 2021
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $215 on, Monday, November 15th, 2021
